| |
| |
|
| Insider
Information: |
Garg Vipin K |
| Relationship: |
President and CEO, Dir... |
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
452,776 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,377,990 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
452,776 |
|
|
| Total
Value |
$2,377,990 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neos Therapeutics, Inc. |
NEOS |
Chief Executive Officer |
2018-03-01 |
160,748 |
|
0 |
Premium* |
|
|
Altimmune, Inc |
ALT |
President and CEO, Dir... |
2024-02-02 |
292,028 |
2018-11-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
63 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NEOS |
Neos Therapeutics, Inc. |
Chief Executive OfficerOfficer |
• • – |
2015-07-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
142,049 |
|
- |
|
| NEOS |
Neos Therapeutics, Inc. |
President, CEO & Director |
• • – |
2015-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
144,549 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2017-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
150,643 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
160,748 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2018-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
322,907 |
322,907 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2022-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,545 |
300,503 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2023-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,546 |
246,259 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2023-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,950 |
257,551 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2024-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,775 |
276,030 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2024-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,545 |
288,767 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2024-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,950 |
300,404 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2023-07-31 |
4 |
A |
$2.81 |
$354 |
D/D |
126 |
249,255 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2020-01-30 |
4 |
D |
$1.77 |
$3,567 |
D/D |
(2,015) |
314,917 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2019-12-30 |
4 |
D |
$1.80 |
$3,598 |
D/D |
(1,999) |
316,932 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2020-03-31 |
4 |
D |
$3.02 |
$6,088 |
D/D |
(2,016) |
322,175 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2020-04-30 |
4 |
D |
$3.05 |
$6,146 |
D/D |
(2,015) |
320,160 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2020-02-29 |
4 |
D |
$3.70 |
$7,456 |
D/D |
(2,015) |
324,191 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2021-01-31 |
4 |
A |
$12.14 |
$12,808 |
D/D |
1,055 |
313,178 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2022-04-30 |
4 |
D |
$4.52 |
$13,596 |
D/D |
(3,008) |
283,826 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2022-05-30 |
4 |
D |
$5.03 |
$15,130 |
D/D |
(3,008) |
280,818 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2020-01-31 |
4 |
A |
$1.46 |
$16,482 |
D/D |
11,289 |
326,206 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2022-01-30 |
4 |
D |
$7.20 |
$16,956 |
D/D |
(2,355) |
281,201 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Chief Financial Officer |
• • – |
2020-07-31 |
4 |
A |
$1.46 |
$17,044 |
D/D |
11,674 |
325,789 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2022-03-30 |
4 |
D |
$6.05 |
$18,192 |
D/D |
(3,007) |
286,834 |
0 |
- |
|
| ALT |
Altimmune, Inc |
President and CEO |
• • – |
2020-05-30 |
4 |
D |
$9.28 |
$18,699 |
D/D |
(2,015) |
318,145 |
0 |
- |
|
63 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
